Zimmer Biomet (ZBH) Stock Price & AI Analysis

NYSE
USA

$110.52

$0.96
(0.88%)

Subscribe to get
AI Score

Zimmer Biomet Company Profile

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Zimmer Biomet | Latest news

SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings?

The global orthopedic space has seen significant transformative changes in recent times. Major...

Zacks - 9 months ago

ZBH Stock Might Rise Following FDA Nod for OsseoFit

Zimmer Biomet Holdings, Inc. ZBH recently received Food and Drug Administration ("FDA") 510(k) clearance for the OsseoFit Stemless Shoulder System for...

Zacks - 1 month ago

Is Zimmer Biomet (ZBH) an Undervalued Defensive Stock for 2025?

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are...

Insider Monkey - 3 days ago

ZBH Stock to Benefit From Global Expansion Despite Macro Issues

Zimmer Biomet's ZBH strategic product launches and stabilizing market trends bolster our confidence...

Zacks - 1 month ago

Here's Why You Should Retain Zimmer Biomet (ZBH) for Now

Zimmer Biomet ZBH is well-poised for growth in the coming quarters, backed by the business rebound...

Zacks - 2 years ago

Zimmer Biomet Holdings, Inc. (ZBH): Why Is It Among the Best Cosmetic Surgery...

We recently compiled a list of the 10 Best Cosmetic Surgery and Aesthetics Stocks To Buy. In this...

Insider Monkey - 5 months ago

ZBH or ABT: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Products sector might want to consider either Zimmer...

Zacks - 1 year ago

ZBH vs. LMAT: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet...

Zacks - 2 years ago

Zimmer Biomet (ZBH) Rides on ROSA Uptake, Favorable Trend

Zimmer Biomet's ZBH strategic focus on ROSA Robotic Platform and stabilizing market trends bolster...

Zacks - 10 months ago

Jim Cramer on Zimmer Biomet Holdings, Inc. (ZBH): ‘This Stock’s Actually Down...

We recently compiled a list of the Jim Cramer’s ‘Ignore the Chatter’ Guide: 10 Stocks to Buy Today....

Insider Monkey - 5 months ago